SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-24-007752
Filing Date
2024-02-14
Accepted
2024-02-14 10:00:16
Documents
1
Group Members
DAVID C. OTTKAVRA 104 LLCO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LPVIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLCVIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLCVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20021473_sc13ga.htm SC 13G/A 430594
  Complete submission text file 0001140361-24-007752.txt   432770
Mailing Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901
Business Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Subject) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91647 | Film No.: 24633392
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)